Janux Therapeutics (JANX) Gains from Sales and Divestitures (2024 - 2026)
Janux Therapeutics (JANX) reported Gains from Sales and Divestitures of $120456.0 for Q1 2026, up 672.75% quarter-over-quarter from $15588.0 in Q4 2025.
Janux Therapeutics (JANX) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 3 years of Gains from Sales and Divestitures data on file, last reported at $120456.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $120456.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $120456.0 (changed N/A YoY), and the FY2025 annual result was $15588.0, up 523.52% from the prior year.
- Gains from Sales and Divestitures grew to $120456.0 in Q1 2026 per JANX's latest filing, from $15588.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $120456.0 in Q1 2026 and troughed at $2500.0 in Q3 2024.
- A 3-year average of $25636.5 and a median of $6387.5 in 2024 frame the typical range for Gains from Sales and Divestitures.
- On a YoY basis, Gains from Sales and Divestitures climbed as much as 523.52% in 2025 and fell as far as 311.0% in 2025.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $2500.0 in 2024, then surged by 523.52% to $15588.0 in 2025, then jumped by 672.75% to $120456.0 in 2026.
- Business Quant data shows JANX's Gains from Sales and Divestitures at $120456.0 in Q1 2026, $15588.0 in Q4 2025, and $10275.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Janux Therapeutics | 892.99 Mn | 892.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,456.00 |
| Mar 31, 2026 | 120,456.00 |
| Dec 31, 2025 | 15,588.00 |
| Dec 31, 2025 | 15,588.00 |
| Sep 30, 2025 | 10,275.00 |
| Sep 30, 2025 | 10,275.00 |
| Jun 30, 2025 | 2,500.00 |
| Jun 30, 2025 | 2,500.00 |
| Dec 31, 2024 | 2,500.00 |
| Dec 31, 2024 | 2,500.00 |
| Sep 30, 2024 | 2,500.00 |
| Sep 30, 2024 | 2,500.00 |